ALLMedicine™ Thermal Burns Center

Aug 2nd, 2022 - This pilot study is being conducted to establish safety, however the study team will make multiple measures to measure for efficacy as well. The study team hypothesizes that human split-thickness skin grafts will safely respond similar to the porc...

Jul 27th, 2022 - A total of 160 patients will be randomized into NexoBrid and SOC treatment (80 patients per arm). Age distribution will be managed as follows: 45 patients 0-23 months old 45 patients 24 months-3 years old 30 patients 4-11 years old 20 patients 12-...

Jul 26th, 2022 - Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the patient's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns. It works to close the woun...

Jul 8th, 2022 - Thermal burn injuries are common, devastating medical emergencies that are challenging to manage. Timely and effective treatment is paramount to both short- and long-term patient outcomes. Currently, medical providers and health care facilities wo...

Jun 17th, 2022 - Platelets exert important roles in burn wound healing and involving in inflammatory regulation and tissue repair. Platelet distribution width (PDW) is an indicator representing platelet morphology and activation. In this study, we try to evaluate ...

Aug 2nd, 2022 - This pilot study is being conducted to establish safety, however the study team will make multiple measures to measure for efficacy as well. The study team hypothesizes that human split-thickness skin grafts will safely respond similar to the porc...

Jul 27th, 2022 - A total of 160 patients will be randomized into NexoBrid and SOC treatment (80 patients per arm). Age distribution will be managed as follows: 45 patients 0-23 months old 45 patients 24 months-3 years old 30 patients 4-11 years old 20 patients 12-...

Jul 26th, 2022 - Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the patient's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns. It works to close the woun...

Jun 8th, 2022 - Multi-center, prospective, randomized, double-blind, parallel-group, within-subject Vehicle controlled, safety and efficacy trial involving subjects with two comparable (similar body location, similar burn area and burn severity), noncontiguous de...

Apr 27th, 2022 - This is an open-label, randomized, active-controlled pilot study to evaluate the efficacy and safety profile of topical MW-III versus an active control (Silvadene® Cream 1% [Silver Sulfadiazine]) in the treatment of second-degree thermal burns in ...

Jun 18th, 2021 - The US Food and Drug Administration (FDA) has approved a novel regenerative therapy that could be an alternative to autografting for treating adults with severe burns. The new treatment, StrataGraft, is a bilayer tissue engineered to mimic the epi...

Dec 3rd, 2020 - To the Editor: Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a curious disorder that has undergone many clinical transformations since first being described by Andersen et al1 in 1984 using the term baboon syndrome. Init.

Oct 2nd, 2020 - Clinical practice guidelines on the management of acute pain in the adult burn patient were released in September 2020 by the American Burn Association.[1] Elements of the pain assessment are as follows: Perform several times daily. Follow a proto...

Jun 30th, 2020 - June 30 (Reuters) - Vericel Corp: * VERICEL ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE FDA FOR NEXOBRID FOR THE TREATMENT OF SEVERE THERMAL BURNS * VERICEL - VERICEL HOLDS AN EXCLUSIVE LICENSE FOR NORTH AMERICAN COMMERCIAL RIGHTS...

Jun 9th, 2020 - June 9 (Reuters) - Mallinckrodt Plc: * MALLINCKRODT COMPLETES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR STRATAGRAFT® REGENERATIVE SKIN TISSUE TO U.S. FOOD AND DRUG ADMINISTRATION * MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE IS IN DEV...